Gain practical insights into understanding and responding to the evolving needs of people living with CML, from diagnosis through treatment and beyond.
This webinar will discuss the use of antibody-drug conjugates (ADCs) and associated proactive toxicity management to assist patients to adhere to their treatment protocols therefore improving patient outcomes.
